ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Investigation of SOCS-3 gene methylation and downstream effects in BCR-ABL-positive CML cells resistant to imatinib found that this epigenetic effect resulted in STAT3 protein activation that led to uncontrolled cell proliferation [31].